Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus

Journal of the American Academy of Dermatology

Volumn 57, Issue 5, 2007, Pages 806-813

  Gorouhi, Farzam ^a   Solhpour, Amirreza ^a   Beitollahi, Jalil Momen ^b   Afshar, Shahla ^b   Davari, Parastoo ^a   Hashemi, Pantea ^a   Nassiri Kashani, Mansour ^a   Firooz, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Dental Research Center TUMS   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

PIMECROLIMUS; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; LICHEN PLANUS; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADULT; DERMATOLOGIC AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; SICKNESS IMPACT PROFILE; SINGLE-BLIND METHOD; TACROLIMUS; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 35148887231     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.06.022     Document Type: Article

References (39)

1. Axell T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol 15 (1987) 46-51
2. Altman J., and Perry H.O. The variations and course of lichen planus. Arch Dermatol 84 (1961) 179-191
3. Eisen D., Carrozzo M., Bagan Sebastian J.V., and Thongprasom K. Number V oral lichen planus: clinical features and management. Oral Dis 11 (2005) 338-349
4. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 46 (2002) 207-214
5. Lodi G., Scully C., Carrozzo M., Griffiths M., Sugerman P.B., and Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting, part 2; clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 (2005) 164-178
6. Chan E.S., Thornhill M., and Zakrzewska J. Interventions for treating oral lichen planus. Cochrane Database Syst Rev 2 (2000) CD001168
7. Zegarelli D.J. Multimodality steroid therapy of erosive and ulcerative oral lichen planus. J Oral Med 38 (1983) 127-130
8. Stoppoloni G., Prisco F., Santinelli R., Sicuranza G., and Giordano C. Potential hazards of topical steroid therapy. Am J Dis Child 137 (1983) 1130-1131
9. Passeron T., Lacour J.P., Fontas E., and Ortonne J.P. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Arch Dermatol 143 (2007) 472-476
10. Van Leent E.J., Graber M., Thurston M., Wagenaar A., Spuls P.I., and Bos J.D. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 134 (1998) 805-809
11. Thongprasom K., Luangjarmekorn L., Sererat T., and Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 21 (1992) 456-458
12. Scott J., and Huskisson E.C. Graphic representation of pain. Pain 2 (1976) 175-184
13. Slade G.D. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol 25 (1997) 284-290
14. Scully C., Eisen D., and Carrozzo M. Management of oral lichen planus. Am J Clin Dermatol 1 (2000) 287-306
15. Carrozzo M., Uboldi de C.M., Dametto E., Fasano M.E., Arduino P., Broccoletti R., et al. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 122 (2004) 87-94
16. Byrd J.A., Davis M.D., Bruce A.J., Drage L.A., and Rogers III R.S. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol 140 (2004) 1508-1512
17. Morrison L., Kratochvil III F.J., and Gorman A. An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 47 (2002) 617-620
18. Allen B.R., Lakhanpaul M., Morris A., Lateo S., Davies T., Scott G., et al. Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. Arch Dis Child 88 (2003) 969-973
19. Meingassner J.G., Kowalsky E., Schwendinger H., Elbe-Burger A., and Stutz A. Pimecrolimus does not affect Langerhans cells in murine epidermis. Br J Dermatol 149 (2003) 853-857
20. Billich A., Aschauer H., Aszodi A., and Stuetz A. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 269 (2004) 29-35
21. Gupta A.K., and Chow M. Pimecrolimus: a review. J Eur Acad Dermatol Venereol 17 (2003) 493-503
22. Dissemond J., Schroter S., Franckson T., Herbig S., and Goos M. Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus. Br J Dermatol 150 (2004) 782-784
23. Esquivel-Pedraza L., Fernandez-Cuevas L., Ortiz-Pedroza G., Reyes-Gutierrez E., and Orozco-Topete R. Treatment of oral lichen planus with topical pimecrolimus 1% cream. Br J Dermatol 150 (2004) 771-773
24. Swift J.C., Rees T.D., Plemons J.M., Hallmon W.W., and Wright J.C. The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus. J Periodontol 76 (2005) 627-635
25. Firooz A., Solhpour A., Gorouhi F., Daneshpazhooh M., Balighi K., Farsinejad K., et al. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Arch Dermatol 142 (2006) 1066-1067
26. Kreuter A., Gambichler T., Breuckmann F., Pawlak F.M., Stucker M., Bader A., et al. Pimecrolimus 1% cream for cutaneous lupus erythematosus. J Am Acad Dermatol 51 (2004) 407-410
27. Boms S., Gambichler T., Freitag M., Altmeyer P., and Kreuter A. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. BMC Dermatol 4 (2004) 14
28. Bohm M., Bonsmann G., and Luger T.A. Resolution of lichen aureus in a 10-year-old child after topical pimecrolimus. Br J Dermatol 151 (2004) 519-520
29. Ungphaiboon S., Nittayananta W., Vuddhakul V., Maneenuan D., Kietthubthew S., Wongpoowarak W., et al. Formulation and efficacy of triamcinolone acetonide mouthwash for treating oral lichen planus. Am J Health Syst Pharm 62 (2005) 485-491
30. Thongprasom K., Chaimusig M., Korkij W., Sererat T., Luangjarmekorn L., and Rojwattanasirivej S. A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus. J Oral Pathol Med 36 (2007) 142-146
31. Vincent S.D. Diagnosing and managing oral lichen planus. J Am Dent Assoc 122 (1991) 93-94 96
32. Ellepola A.N., and Samaranayake L.P. Adjunctive use of chlorhexidine in oral candidoses: a review. Oral Dis 7 (2001) 11-17
33. Rappersberger K., Komar M., Ebelin M.E., Scott G., Burtin P., Greig G., et al. Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated. J Invest Dermatol 119 (2002) 876-887
34. Voute A.B., de Jong W.F., Schulten E.A., Snow G.B., and van der Waal I. Possible premalignant character of oral lichen planus: the Amsterdam experience. J Oral Pathol Med 21 (1992) 326-329
35. Brown R.S., Bottomley W.K., Puente E., and Lavigne G.J. A retrospective evaluation of 193 patients with oral lichen planus. J Oral Pathol Med 22 (1993) 69-72
36. Zheng T.Z., Boyle P., Hu H.F., Duan J., Jian P.J., Ma D.Q., et al. Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing, People's Republic of China. Cancer Causes Control 1 (1990) 235-241
37. Berger T.G., Duvic M., Van Voorhees A.S., VanBeek M.J., and Frieden I.J. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association task force. J Am Acad Dermatol 54 (2006) 818-823
38. Spergel J.M., and Leung D.Y. Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence. Curr Allergy Asthma Rep 6 (2006) 270-274
39. Stern R.S. Topical calcineurin inhibitors labeling: putting the "box" in perspective. Arch Dermatol 142 (2006) 1233-1235